The impact of HER2 discordance on patient prognosis following anti-HER2 neoadjuvant therapy for HER2-positive breast cancer.

Ren Y, Su T, Gong Z, Li G, Feng H, Feng X, Zhou S, Xing W

Open source

DOI
10.3389/fonc.2026.1889796
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1889796,
  title = {The impact of HER2 discordance on patient prognosis following anti-HER2 neoadjuvant therapy for HER2-positive breast cancer.},
  author = {Ren Y and Su T and Gong Z and Li G and Feng H and Feng X and Zhou S and Xing W},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1889796},
  url = {https://doi.org/10.3389/fonc.2026.1889796}
}

RIS

TY  - JOUR
TI  - The impact of HER2 discordance on patient prognosis following anti-HER2 neoadjuvant therapy for HER2-positive breast cancer.
AU  - Ren Y
AU  - Su T
AU  - Gong Z
AU  - Li G
AU  - Feng H
AU  - Feng X
AU  - Zhou S
AU  - Xing W
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1889796
UR  - https://doi.org/10.3389/fonc.2026.1889796
ER  - 

APA

Y, R., T, S., Z, G., G, L., H, F., X, F., S, Z., & W, X. (2026). The impact of HER2 discordance on patient prognosis following anti-HER2 neoadjuvant therapy for HER2-positive breast cancer.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1889796

Source records